Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management

Abstract Beta-adrenergic receptor blockers are used in patients with coronary artery disease (CAD) to reduce the harmful effects of excessive adrenergic activation on the heart. However, there is limited evidence regarding the benefit of beta-blockers in the context of contemporary management follow...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pil Hyung Lee, Gyung-Min Park, Seungbong Han, Yong-Giun Kim, Jong-Young Lee, Jae-Hyung Roh, Jae-Hwan Lee, Young-Hak Kim, Seung-Whan Lee
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2020-12-01
coleção:	Scientific Reports
Acesso em linha:	https://doi.org/10.1038/s41598-020-79214-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!